USPTO serial 79304500
Serial No. 79304500
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 22, 2022
- Examiner
- CLARK, ANDREW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79304500?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations for treating chronic pain; medical and veterinary preparations for treating chronic pain; medicines for treating chronic pain; medicinal preparations and substances for treating chronic pain; pharmaceutical preparations and substances for treating chronic pain; diagnostic reagent substances for medical use; reagents and preparations for medical and veterinary diagnostic purposes; preparations for the relief of pain | ACTIVE | — |
| 009 | Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Downloadable computer software for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; downloadable software applications for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease ; downloadable data processing computer software; downloadable software for medical use for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; Downloadable computer software using artificial intelligence for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; downloadable computer application software for transmitting, receiving and analyzing video communications, two-way video, voice and text conferencing for collecting health-related data, diagnosing pain, defining treatment based on the diagnosis and administering appropriate pain treatment, either directly to the patient, the healthcare professional or the pharmaceutical entity; downloadable computer application software for measuring, analyzing, preventing, alleviating and managing pain; downloadable database management software; downloadable computer software for enabling the searching and retrieval of data; downloadable databases in the field of the relief of pain; data processing apparatus; electronic data processing apparatus | ACTIVE | — |
| 010 | Medical apparatus and instruments for treating pain; medical diagnostic apparatus and instruments for treating chronic pain; tools for medical diagnosis for treating chronic pain; medical instruments for monitoring vital signs of patients; pain measuring device for medical use; pain analysis device for medical use; instruments for medical use for use in treating pain; medical apparatus and instruments, namely, pain relief instruments for medical use | ACTIVE | — |
| 042 | Scientific research and development; medical and pharmacological research services; Technical research in the field of pharmaceutical studies; biological, clinical and medical research services in the field of pain management; research and development of new products; medical research laboratory; laboratory testing services, namely, laboratory analysis in the field of pain management; scientific research and analysis; research and development relating to software; Outsource service providers in the field of information technology; new product design services, namely, design and development of medical technologies; development of databases; maintenance of database software; technical project studies, namely, scientific study and research in the field of pain management; technical research in the field of software, namely, project studies concerning software; design and development of software for use in the framework of medical technology; Software as a service (SAAS) services for medical use featuring software for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; application service provider (ASP), namely, hosting software as a service (SAAS) software of others in the field of digital health services; Software as a service (SAAS) services, namely, hosting software for use by others for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; computer platform as a service (PaaS) featuring software platforms for transmission of images, audiovisual content, video content and messages; computer programming; design and development of software application solutions; design and development of medical diagnostic apparatus; design and development of computer hardware and software for use in the medical field; development of data processing programs; electronic data storage and backup services; Information technology (IT) consulting services in the field of securing computer data; technical data analysis services, namely, compiling data for research purposes in the field of medical science and medical consultancy; provision of information relating to medical and scientific technology research; provision of information and data relating to medical and veterinary research and development; information technology (IT) consulting services, namely, advice relating to information technology intended for the pharmaceutical and health industries | ACTIVE | — |
| 044 | Medical and health care services; medical services in the field of chronic pain treatment; telemedicine services; advisory services relating to health care; medical diagnostic testing and analysis services; medical evaluation services of pain; conducting of pain studies for medical diagnostic or treatment purposes; medical information; provision of health care information in the field of prevention, screening, diagnosis and treatment of pain; health care services, namely, providing therapeutic treatment of pain; health care services, namely, therapeutic services against pain; health care services, namely, providing therapeutic treatment of pain via the internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LUCINE
- Other trademarks owned by LUCINE
- Other trademarks owned by LUCINE
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 29, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 29, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 22, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 26, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 26, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 16, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 29, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 29, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 29, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 29, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 17, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |